HomeAI · summaries
Storia in 3 fonti
Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator
The new recommendation will significantly expand access to Wegovy on the England's NHS.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
Wegovy Subscription Launched—Here’s How Much It Could Save Users A Year
Novo Nordisk says people will save up to $1,200 per year on the Wegovy injection and $600 per year on the pill under the new program.
- ·
cnbc.com
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly
Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.
